Previous 10 | Next 10 |
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference in London, UK on Thursday, November 16, 2023 at 1:30 p.m. GMT/8:30 a.m. ET. A live webcast of the fireside chat ...
2023-11-03 12:24:06 ET GlycoMimetics, Inc. (GLYC) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Company Participants Christian Dinneen-Long - General Counsel Harout Semerjian - Chief Executive Officer Edwin Rock - Chief Medical Officer Brian Ha...
2023-11-03 07:11:37 ET More on GlycoMimetics GlycoMimetics: Q2 2024 Data Readout Makes This Worth A Look, But Cash Is A Problem GlycoMimetics chief medical officer Rock buys 65.4K shares Seeking Alpha’s Quant Rating on GlycoMimetics Historical earnings...
HST Global Inc (HSTC) is expected to report for quarter end 2023-09-30 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 GrafTech International Ltd. (EAF) is expected to report $-0.05 for Q3 2023 Cardinal Health Inc. (CAH) is expected to report $1.4 for Q1 2024 ...
Topline results from pivotal Phase 3 study of uproleselan in relapsed/refractory (R/R) Acute Myeloid Leukemia (AML) on track to be reported by end of Q2 2024 NDA filing for uproleselan anticipated by end of 2024 pending outcome of R/R AML pivotal study Initial results for GMI-1687 Phase 1...
GlycoMimetics Inc. (GLYC) is expected to report $-0.14 for Q3 2023
2023-11-02 11:16:09 ET Major earnings expected before the bell on Friday include: Dominion Energy ( D ) Enbridge ( ENB ) EOG Resources ( EOG ) fuboTV ( FUBO ) W. P. Carey ( WPC ) For further details see: Notable earnings before Friday's open
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board PR Newswire SAN JOSE, Calif. , Oct. 23, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NA...
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report third quarter 2023 financial results on Friday, November 3, 2023, at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you will be provided with d...
2023-09-26 11:20:50 ET More on GlycoMimetics Seeking Alpha’s Quant Rating on GlycoMimetics Historical earnings data for GlycoMimetics Financial information for GlycoMimetics GlycoMimetics: Q2 2024 Data Readout Makes This Worth A Look, But Cash Is A Pro...
News, Short Squeeze, Breakout and More Instantly...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 0.18% to 38,7...